Rankings
▼
Calendar
INVA Q4 2016 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$44M
Gross Profit
$43M
99.2% margin
Operating Income
$38M
86.4% margin
Net Income
$25M
58.4% margin
EPS (Diluted)
$0.22
QoQ Revenue Growth
+30.9%
Cash Flow
Operating Cash Flow
$21M
Free Cash Flow
$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$379M
Total Liabilities
$732M
Stockholders' Equity
-$353M
Cash & Equivalents
$118M
← FY 2016
All Quarters
Q1 2017 →